Next Article in Journal
The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines
Next Article in Special Issue
Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience
Previous Article in Journal
New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer—Current State and Molecular Pathology Perspective
 
 
Commentary

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 24 December 2024 17:11 CET Version of Record https://www.mdpi.com/2072-6694/17/1/18/pdf-vor
article xml file uploaded 25 December 2024 11:30 CET Original file -
article xml uploaded. 25 December 2024 11:30 CET Update https://www.mdpi.com/2072-6694/17/1/18/xml
article pdf uploaded. 25 December 2024 11:30 CET Updated version of record https://www.mdpi.com/2072-6694/17/1/18/pdf
article html file updated 25 December 2024 11:31 CET Original file https://www.mdpi.com/2072-6694/17/1/18/html
Back to TopTop